Rivera, Ava .
HRN: 19-65-24 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/10/2022
AMPICILLIN 250MG (VIAL)
07/10/2022
07/17/2022
IV
200mg
Q6h
URTI
Waiting Final Action
Indication: Empiric Type of Infection: URTI Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes